Modulation of the urokinase-type plasminogen activator receptor by the beta 6 integrin subunit

Dalvi, Nafisa, Thomas, Gareth J., Marshall, John F., Morgan, Mark, Bass, Rosemary, Ellis, Vincent, Speight, Paul M. and Whawell, Simon A. (2004) Modulation of the urokinase-type plasminogen activator receptor by the beta 6 integrin subunit. Biochemical and Biophysical Research Communications, 317 (1). pp. 92-99. ISSN 0006-291X

Full text not available from this repository. (Request a copy)


Over-expression of components of the urokinase system is well documented in cancer and is thought to enable tumour cells to migrate and invade. Changes in integrin expression are also a common feature of tumours and have been linked to changes in protease activity. It has been shown that the *vβ6 integrin is neo-expressed in a number of epithelial carcinomas and in wound healing situations. We therefore investigated whether *vβ6 is able to modulate a key regulator of proteolysis, the urokinase receptor. We report that epithelial cells expressing full-length *vβ6 exhibit decreased urokinase receptor expression and function. Furthermore, this novel modulation requires the C-terminal 11 amino acids of the cytoplasmic tail of the β6 integrin subunit. Cells expressing *vβ3, however, did not affect urokinase receptor expression. De novo expression of β6 by melanoma cells and β3 by epithelial cells did not influence urokinase receptor expression or function, suggesting that modulation of urokinase system is both integrin subunit and cell-specific.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Science > School of Biological Sciences
UEA Research Groups: Faculty of Science > Research Groups > Cells and Tissues
Depositing User: EPrints Services
Date Deposited: 01 Oct 2010 13:37
Last Modified: 24 Jul 2024 08:22
DOI: 10.1016/j.bbrc.2004.02.178

Actions (login required)

View Item View Item